Luminal gas–liquid interfaces in the gastrointestinal tract

The luminal gas-liquid interface in the gastrointestinal tract represents the physical boundary between intestinal gases and the surrounding liquid or mucus layer. This interface is a critical site for the formation of foam, where small gas bubbles are trapped within a viscous liquid medium, often leading to symptoms such as bloating, abdominal pain, and flatulence (StatPearls, 2023). Pharmacological intervention at this interface typically involves the use of antifoaming agents like simethicone, which act as surfactants. By reducing the surface tension of these interfaces, these agents cause the small, stable bubbles to coalesce into larger volumes of gas that can be more readily expelled through belching or flatus (PubChem, 2024). This target is primarily physical rather than biochemical, as the drugs involved are chemically inert and do not interact with specific receptors or enzymes (NIH, 2022). Beyond symptomatic relief, targeting these interfaces is also clinically significant during diagnostic procedures like endoscopy or ultrasound to improve visualization by clearing obstructive foam (Journal of Clinical Gastroenterology, 2014). Because the target is a physical interface, the therapeutic effect is localized and does not involve systemic absorption of the active agent.

Other names

Gastrointestinal gas-liquid interfaceIntestinal gas bubblesMucus-gas interfaceIntestinal foam

Reduction of surface tension at the gas-liquid interface, leading to the coalescence and rupture of small gas bubbles into larger ones that are more easily eliminated.